Delivery Order SPE2DR25D1052-SPE2DR26F6CM2
- Not listed
- The Defense Logistics Agency awarded a $15,557.18 delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) with an ultimate completion date of November 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $17,616.07 to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL) pen injections on December 15, 2025, with completion scheduled for December 16, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement supporting federal medical supply requirements. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Forteo (560 mcg/2.24 ml pen injection) valued at $4,239.43 with a firm fixed price structure. This is a non-set-aside contract with an ultimate completion date of June 20, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal contracting...
- The Defense Logistics Agency awarded a delivery order valued at $15,973.73 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injection), a pharmaceutical product used in treating osteoporosis. The contract was awarded on December 9, 2025, with an ultimate completion date of December 10, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $13,965.22 delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price contract, which was competitively awarded with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical. The contract will be performed at the company's corporate office...
- The Defense Logistics Agency awarded a $3,666.64 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This is a firm fixed price, non-set-aside contract with a completion date of September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Forteo is a prescription medication used to treat osteoporosis and increase bone density, and this order represents a...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) with an ultimate completion date of August 22, 2025. This non-competitive delivery order represents a single pharmaceutical procurement from the company's extensive federal contract portfolio. The place of performance is identified as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $7,804.29 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) with an ultimate completion date of July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded on July 24, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) valued at $2,601.43. This non-set-aside, firm fixed-price delivery order was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $22,105.54 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This contract represents a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and is being performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was utilized for this competitive award. This delivery order is issued under AmerisourceBergen Drug...
- SPE2DR25D1052Indefinite Delivery Contract
- SPE2DR25D1052-SPE2DR26F6CM2Delivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) valued at $8,224.53, with an ultimate completion date of December 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Forteo, a medication used primarily for osteoporosis treatment, represents one of numerous specialty pharmaceuticals and branded medications delivered through this framework to support Department of Defense medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 12/17/25 |